“To be able to have a new generation antibiotic, to be used in a specific and targeted way on particular resistant strains and effective in reducing deaths and complications, it can really represent a significant turning point for patients “, underlines Matteo Bassetti, director of the Infectious Diseases Clinic of the San Martino Polyclinic in Genoa
